Member Info for PRO_TRADER

Holding here very long time lIke many others I guess. Based on the last presentation and the remaining cash flow it seems to me that they will fall short and they will need a bit more money until they breakeven, without of course being sure but more likely this will be the case scenario. Everything depends on what sales they will achieve, let’s wait and see. On the other hand shield is undervalued if you look at it long term and what they can achieve, especially once the Asian countries are joined It is simply a matter of time if you can wait.

Hello there, yes of course I mean 5 pence, this is what I foresee, without of course be 100% sure but from experience that is a classical example of bump and dump. It doesn't matter what the company has, it matters if they make profit or not, at the moment they make nothing and I presume they will not make any profit over the next 5 years until to unfold their assets and sell them. That means borrowing money, then dilution etc. The share pruce will eventually drift down. On the other hand as I wrote just follow the chart, it was clearly shown that at 50 pence you should get out or short it and wait. It has hit the resistance level followed by a big red candle, then the dowtrend started.

This is heading towards 5p, you should short it instead of buying, I wrote about it approximately 10 days ago, whatever goes up fast will come down fast, this is the rule in stockmarket. Anyway is all about charting at the end, you should use your charts and mark the resistance level, big red candle from there then will start descending. Hope that helps.

This will go down like a ball soon or after, a similar story like Atlantic Lithium and many other exploration companies. Until to get the assets out, sell them and make profit it will probably take minimum 5 years from now or even more. Zero revenues at the moment, then dilution cause they will need money again and again and the story will go on and on. I wouldn't touch this one, instead this is good opportunity for shorting but not right now, need wait a bit.

Totally disagree, 1p in 2028 with current NPV 16p? Absolutely no chance the way the company is going. Yes it might fall further in a case they don't breakeven by the end of 2025 or in a case they will need more money but if you look the whole picture there is nothing wrong, they are heading in the right direction. The share price will be substuntally higher once the Asian countries are joined especially China. We are talking about huge revenues but as always is the case with stock market patience is required. Let's wait and see...

I am keeping a lot of shares of Shield Therapeutics long time now and I can tell you for sure that is one of best investments if you have patience. The company is increasing its revenues on yearly basis, that is they are improving quite well until now, I believe they will make it and breakeven by the end of the year, of course we cannot be sure as it depends in many factors. I think many people here they don't understand how the stock market works mainly because they don't understand what the company can achieve in the long run. Did anybody realise when the Asia countries come into play especially China what revenues Shield will achieve? I am telling you for sure this will be 30p by 2028.

Absolutely correct! That is a long term investment which will not disappoint regardless the mistakes done by the management. Shield has a product that can achieve hunderd of millions in revenues, however to accomplish that it takes time which in this particular case we should be looking into some years from today. Another factor which has to be considered here is that shield has just started and they need money to grow, therefore that is an inevitable fact. Unfortunately many people do not understand how the stock market works and are expecting the sp to take off from one day to the next. I am sure shield will make it eventually, it is only a matter of time.

Personally I am optimistic in the long run. Indeed the management made some mistakes but they managed to triple revenues compared to previous year therefore we see an upward trajectory trend even if fhey slightly missed expectations. We must not forget that they just started and this requires money and time. They process a prduct that can achieve hunderd of millions in revenues especially when the other countries come into play and more specifically china. As you can realize this is a very long process which will pay off well unless a takeover occurs which i doubt it. The fall from 6p is over the top as the market took it very wrong. I own millions of shares with an average price of 6.5 and personally I am not selling not a single share. The stock is extremely undervalued at this price looking always in the long run. There will be some good news coming this year concerning Korea and Canada I guess which will push the share price up. In any case I am not worry at all. I will increase my position once the results in April come out and things will be more clear. No worries for Shield, needs patience and will bounce well back.

Absolutely agree with you, a business with a very strong asset which can achieve hundreds of millions a year in revenue. Indeed serious mistakes have been done by the management, however personally I am optimistic in the long run and I am sure they will make it as the fundamentals are there, especially with the introduction of the drug in the other countries. The main mistake done by the management is that they should talk about revenues and not about prescriptions. The revenues is what it matters and not the prescriptions They had a slow Q4/2023 however the revenues achieved for such a small company started more or less 6 months ago in US market are not bad at all. They will sure need more money until to reach a breakeven point but this is how the stock market works especially for small companies like shield. The fundamentals, the product and potential are all there, need wait and see what they will achieve this year.

Very well and clear presentation showing that the company is progressing very well. The issue here is that they should talk from the very beginning about revenuers and not about prescriptions. They have done exactly what they said and achieved approximately three times more revenues compared to last year. It is very strange to see a company increasing its revenues almost 3 times more and having a share drop of more than 50%. The market took it very wrong thus the fall of the sp. It will certainly bounce back and reaching its target price n the future.

Results are according to expectations showing a tremendous growth compared to last year. Sales are increasing exponentially indicating tremendous future potential. This is what exactly we need to see for the time being. Brilliant future for Shield Therapeutics, no doubt this is a multibagger long term holding. stock

It is normal for stocks to go up and down, definitely if they didn't need any money the share price would be around 15p now. II would say that in this price it is very cheap considering the company potential. This year we will actually be able to see the real potential and growth, let’s have patience.

I am sure they will achieve their targets more or less, probably all year round should be somewhere around 100,000 prescriptions. The most important merit to consider is the company growth compared to the previous year. Dont forget for 2023 they worked only 6 months fully. The 2024 will be the most critical year for shield which I believe theywill hit very high revenues.

I am sure many of us miss the articles below which were recently actually

https://m.uk.investing.com/analysis/shield-therapeutics--ramped-up-and-heading-into-a-stronger-h223-200590607

https://www.edisongroup.com/research/delivering-what-the-doctor-ordered/33034/

That is sure a STONG BUY provided you are not expecting to make money tomorrow from the share price

We are all in the same boat obviously so we need to have patience, it needs time but will go up sure and definitely analysts know better. Even without any analysts opinion everything is clear on the table, revenues are increasing year by year, therefore patience is required, sure will reach higher levels especially when Korea and Canada will come into play. If you look at it long term we are talking about huge revenues so no mistake with this one, it is just a babe now and growing up.

I don't think will miss their target and if so will be slightly. The important thing to consider here is that revenues are increasing steadily and exponentially compared to previous year. The company shows tremendous future potential and definitely the sp will go up well by the end of the year and definitely even higher as other countries like South korea, Canada etc will contribute to higher revenues. Long term you are not going to loose from this one sure. Have a look in the below as well, hope it helps

https://valueinvesting.io/STX.L/estimates

We need to look into the long term growth and potential of the company and not whether they will hit their target 100% in a year time, they might overpass it or they might slightly miss it, the important thing here is that the company sales are exponentially increasing with possibility of tremendous revenues in the long run especially with the admission of the drug into the other countries which certainly needs time. I believe they will need money again in 2025 but this is how it works to achieve a growth. This is a very long process as shield is still a babe. I think we are all in the same situation having shares nearly the current price therefore patience is required here provided you are long term holder. As I wrote in my previous posts I strongly believe will reach 25 - 30p in a year time with a further projection to 50p in the long run unless it is sold out at some stage.

We do not have any other option than have patience, share price will sure go up, that is fact, just needs time and some good news which I see them coming this year. About projected share price I foresee at least 30p by the end of 2024 and rising higher to 50p once the product is launched in the other countries. The potential is huge for shield as it can achieve huge revenues in the long run but for that it takes time. Personally I am not going to sell any shares less than than 50p as I am long term holder.

Patience is the key, this is what we need, there is only one way for Shield, that is an increase in share price but will take time, it is still a babe, sales are increasing thus next results would be much better, coupled with the expected licenses from Hong Kong, Canada etc, I see the share price being projected to 30p and then moving further up to 50p easily and even higher. At this price is really very cheap if you are a long-term holder.

Shield is still a babe and needs time and money to launch the product properly into the market. It will pay well long term holders, no doubt about that. Sales definitely will be increasing exponentially over the next years especially wih the product incorporation into the expected countries as well, hence the share price will increase. Patience is required.